Provencio, M; Terrasa, J; Garrido, P; Campelo, RG; Aparisi, F; Diz, P; Aguiar, D; García-Giron, C; Hidalgo, J; Aguado, C; González, JG; Esteban, E; Gómez-Aldavarí, L; Moran, T; Juan, O; Chara, LE; Marti, JL; Castro, RL; Ortega, AL; Moreno, EM; Coves, J; Peña, AMS; Bosch-Barrera, J; Gastaldo, AS; Núñez, NF; del Barco, E; Cobo, M; Isla, D; Majem, M; Navarro, F; Calvo, V – 2021 – 10.1186/s12885-021-07922-5
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group – BMC CANCER
by prodriguez | Jan 1, 2021 | Publicaciones - B-22 | 0 comments